Aratana Therapeutics will make another go at an IPO this week, joining five other companies slated to go public. More
- ADVERTISEMENT
-
Sponsored By:
-
Sponsored By:
- Poll of the Day
- Partners
- ADVERTISEMENT
- More Financial News
Aratana Therapeutics will make another go at an IPO this week, joining five other companies slated to go public. More
This biotech stock has recently been upgraded, and just announced a $3 billion share buyback program. More
Biogen has been soaring on news of its recent drug approval, but the question remains when it can keep it up. Here are the bullish and bearish arguments. More
Here’s a look at the 10 best performers in the S&P 500, as well as some thoughts about why they have rallied and what’s in store for them for the rest of the year. More
Celgene Corp. (NASDAQ:CELG) broke from a rectangle consolidation, forming a steep bull channel. More
A consolidation in Celgene Corp. is giving traders the perfect opportunity to buy at a bargain. More
It's the hottest sector in the S&P 500 so far this year, and that means some big-name pullbacks are likely. Here are three likely candidates. More